Hologic’s HOLX consistent profitability has led to strong cash flow generation, approximately $1 billion annually, supporting the development of a pristine balance sheet. The company’s capital deployment strategy prioritizes tuck-in acquisitions to access high-growth adjacent markets, followed by share repurchases, mainly to manage dilution and, if needed, to narrow the...